Calidi Biotherapeutics CLDI
NYSE CLDI
$0.68 -0.09 (-11.20%)
As of: Oct 22, 2026 · 2:08 PM EDT

Calidi Biotherapeutics (CLDI) Other Operating Expenses (2022 - 2026)

Updated

Calidi Biotherapeutics' Other Operating Expenses was -$89,000 in Q2 2026, compared with -$96,000 a year earlier.

Analysis

Calidi Biotherapeutics (CLDI) Other Operating Expenses (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Calidi Biotherapeutics' Other Operating Expenses was -$384,000 through Jun 30, 2026; for FY2025, it was -$386,000.

  • In earlier years, Other Operating Expenses was -$402,000 in FY2024, $14,000 in FY2022 (-99.2%) and $1.78 million in FY2021.
  • The Q2 2026 figure marks the highest quarterly Other Operating Expenses since Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,169.76 Bn 1,138.35 Bn 19.71 Bn
2 Johnson & Johnson 648.06 Bn 567.92 Bn 17.30 Bn
3 AbbVie 503.37 Bn 476.48 Bn 12.70 Bn
4 Merck 365.39 Bn 319.77 Bn 12.21 Bn
5 Novartis Ag 303.45 Bn 267.44 Bn 11.24 Bn
6 Astrazeneca 269.03 Bn 242.72 Bn 12.86 Bn
7 Amgen 242.08 Bn 197.48 Bn 7.24 Bn
8 Gilead Sciences 194.88 Bn 169.07 Bn 6.22 Bn
9 Pfizer 172.39 Bn 119.04 Bn 10.94 Bn
10 Calidi Biotherapeutics 965,711.97 -24.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -89,000.00
Dec 31, 2025 -94,000.00
Sep 30, 2025 -105,000.00
Jun 30, 2025 -96,000.00
Dec 31, 2024 -100,000.00
Sep 30, 2024 -99,000.00
Jun 30, 2024 -101,000.00
Jun 30, 2022 361,622.00
Mar 31, 2022 528,858.00
API Access

Calidi Biotherapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=CLDI&period=max&api_key=YOUR_API_KEY